COVID-19感染对肺栓塞患者病死率的影响
合并肺栓塞者院内病死率28.7%,显著高于无肺栓塞者的17.7%;2020年肺栓塞合并COVID-19患者病死率28.7%,远高于单纯肺栓塞患者的12.5%,OR为3.16(95%CI 2.91-3.42;p<0.001)。
要点
- COVID-19住院患者中肺栓塞患病率为1.9%。
- COVID-19合并肺栓塞者院内病死率28.7%,无肺栓塞者17.7%。
- 合并COVID-19使肺栓塞相关死亡风险增加3.1倍。
核心结论
- 德国2020年COVID-19住院患者中肺栓塞患病率与2019年肺栓塞住院数量大致不变,但COVID-19合并肺栓塞者病死率显著高于单一疾病患者,提示两者叠加具有危及生命的附加预后影响。
主要发现
- COVID-19合并肺栓塞患者院内病死率为28.7%,而无肺栓塞的COVID-19患者为17.7%。
- 2020年合并与不合并COVID-19的肺栓塞患者病死率分别为28.7%和12.5%(p<0.001),合并COVID-19时肺栓塞相关死亡风险增加3.1倍(OR 3.16,95%CI 2.91-3.42;p<0.001)。
临床怎么用
- 对COVID-19住院患者应警惕合并肺栓塞,因其显著增加院内死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although a high prevalence of pulmonary embolism (PE) has been reported in association with coronavirus disease 2019 (COVID-19) in critically ill patients, nationwide data on the outcome of hospitalised patients with COVID-19 and PE are still limited. Thus, we investigated seasonal trends and predictors of in-hospital death in patients with COVID-19 and PE in Germany. METHODS: We used a German nationwide inpatient sample to analyse data on hospitalisations among COVID-19 patients with and without PE during 2020, and to detect changes in PE prevalence and case fatality in comparison with 2019. RESULTS: We analysed 176 137 COVID-19 hospitalisations in 2020; PE was recorded in 1.9% (n=3362) of discharge certificates. Almost one-third of patients with COVID-19 and PE died during the in-hospital course (28.7%) compared with COVID-19 patients without PE (17.7%). Between 2019 and 2020, numbers of PE-related hospitalisations were largely unchanged (98 485 versus 97 718), whereas the case fatality rate of PE increased slightly in 2020 (from 12.7% to 13.1%; p<0.001). Differences in case fatality were found between PE patients with and without COVID-19 in 2020 (28.7% versus 12.5%; p<0.001), corresponding to a 3.1-fold increased risk of PE-related death (OR 3.16, 95% CI 2.91-3.42; p<0.001) in the presence of COVID-19. CONCLUSIONS: In Germany, the prevalence of PE events during hospitalisations was similar in 2019 and 2020. However, the fatality rate among patients with both COVID-19 and PE was substantially higher than that in those with only one of these diseases, suggesting a life-threatening additive prognostic impact of the COVID-19-PE combination.
引用
- Hobohm, Sagoschen, Barco, et al. COVID-19 infection and its impact on case fatality in patients with pulmonary embolism. Eur Respir J. 2023. PMID: 35981745. doi:10.1183/13993003.00619-2022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。